SCHEMBL23867532

SCHEMBL23867532

Cc1ccc(Nc2nc(N3CCN(CCO)CC3)nc3nccnc23)cc1Cl

nearest known ligand 0.53

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ SRC P12931 11/20 0.53
▸ HTR2A P28223 8/20 0.48
▸ DRD3 P35462 2/20 0.46
▸ HTR2C P28335 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27248392 0.88 HPGD (0.50) HTR2AHTR2C
SCHEMBL23867520 0.86 TDP1 (0.48) —
SCHEMBL27429930 0.82 L3MBTL1 (0.60) SRC
SCHEMBL27248311 0.80 HPGD (0.58) HTR2AHTR2C
SCHEMBL17716933 0.80 HTR2C (0.50) HTR2AHTR2C
SCHEMBL27429987 0.78 MAPT (0.48) SRCHTR2AHTR2C
SCHEMBL27248325 0.77 HPGD (0.54) HTR2AHTR2C
SCHEMBL27248309 0.77 SRC (0.52) SRCHTR2AHTR2C
SCHEMBL27248322 0.77 L3MBTL1 (0.52) SRCHTR2AHTR2C
SCHEMBL27429484 0.77 BCL6 (0.66) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021195279-A2 SMALL MOLECULE INHIBITORS OF ONCOGENIC CHD1L WITH PRECLINICAL ACTIVITY AGAINST COLORECTAL CANCER THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2021-09-30 — — WO disclosed
Send feedback